• Home
  • News
  • Fortune 500
    • Fortune Global 500
    • Fortune 500 Europe
    • Fortune China 500
    • Fortune SEA 500
    • Great Place to Work
  • Tech
    • AI
    • Innovation
    • Cybersecurity
  • Finance
    • Personal Finance
    • Real Estate
    • Economy
    • Investing
    • Banking
    • Crypto
  • Leadership
    • Success
    • Future of Work
    • Workplace Culture
    • C-Suite
    • CEO Initiative
  • Lifestyle
    • Arts & Entertainment
    • Travel & Leisure
    • Health
    • Well
    • Education
  • Rankings
    • Analytics
  • Multimedia
    • Live Media
    • Magazine
    • Newsletters
    • Video
    • Podcasts
  • Home
  • News
  • Fortune 500
    • Fortune 500
    • Fortune Sea 500
    • Fortune 500 Europe
    • Fortune Global 500
    • Fortune China 500
    • Great Place To Work
  • Tech
    • Tech
    • Ai
    • Innovation
    • Cybersecurity
  • Finance
    • Finance
    • Personal Finance
    • Real Estate
    • Economy
    • Banking
    • Investing
    • Crypto
  • Leadership
    • Leadership
    • Success
    • Future Of Work
    • Workplace Culture
    • C-suite
    • Ceo Initiative
  • Lifestyle
    • Lifestyle
    • Arts & Entertainment
    • Travel & Leisure
    • Health
    • Well
    • Education
  • Rankings
    • Rankings
    • Analytics
  • Multimedia
    • Multimedia
    • Live Media
    • Magazine
    • Newsletters
    • Video
    • Podcasts
  • Asia
  • Europe
  • Analytics

Paul Hudson

Stay informed with Paul Hudson’s coverage and analysis for Fortune.

  • Paul HudsonCommentary

    Sanofi CEO: AI might beat IQ, not EQ — but never say never

    By Paul Hudson
  • Paul Hudson, chief executive officer of Sanofi SA, during a panel session on day two of the World Economic Forum (WEF) in Davos, Switzerland, on Wednesday, Jan. 17, 2024. The annual Davos gathering of political leaders, top executives and celebrities runs from January 15 to 19. Photographer: Hollie Adams/Bloomberg via Getty ImagesCommentary

    Sanofi CEO: AI promises a great era of drug discovery that could fundamentally change medicine–but only if we allow it to deliver

    By Paul Hudson
  • Joyce Mullen, CEO of Insight, and Paul Hudson, CEO of Sanofi.Commentary

    Sanofi and Insight Enterprises CEOs: With the right blueprint in place, AI will empower workers and help big companies become more nimble

    By Paul Hudson and Joyce Mullen
  • Central Islip, N.Y.: People cover their nose as they walk in Central Islip, New York on June. 7, 2023, due to smoky conditions caused by wildfires in Canada. (Photo by James Carbone/Newsday RM via Getty Images)Commentary

    Climate change is our greatest health crisis. The same investments can often address both threats

    By Vanessa Kerry and Paul Hudson
  • Chief Executive Officer of French pharmaceutical group Sanofi Paul Hudson presents the group’s 2021 full year results at Sanofi headquarters in Paris on February 4, 2022. (Photo by Eric PIERMONT / AFP) (Photo by ERIC PIERMONT/AFP via Getty Images)Commentary

    Sanofi CEO: ‘Europe’s lead in life sciences R&D is eroding–but co-localized hubs could allow it to keep up’

    By Paul Hudson
  • Doctor talking to the patient about menopause and treatment in future.Commentary

    People are much less likely to trust the medical system if they are from an ethnic minority, have disabilities, or identify as LGBTQ+, according to a first-of-its-kind study by Sanofi

    By Paul Hudson and Michelle A. Williams
  • VESPASIANO, BRAZIL – JULY 07: A lab technician works on a patient’s samples to perform COVID-19 PCR tests at Hermes Pardini Lab amidst the coronavirus (COVID-19) pandemic on July 7, 2020 in Vespasiano, Brazil. Hermes Pardini is the largest diagnostic medicine lab in Latin America and since March has performed over 200,000 COVID-19 PCR tests. (Photo by Pedro Vilela/Getty Images)Commentary

    Pharma’s sense of urgency must outlast the pandemic

    By Paul Hudson
  • Cancer treatments like immunotherapy can cause serious side effects, writes Sanofi CEO Paul Hudson.Commentary

    How new technologies are transforming cancer treatment

    By Paul Hudson
  • vaccine injectionsCommentary

    How to speed up medical breakthroughs in the post-COVID world

    By Paul Hudson
  • A healthcare professional performs a serological test that can identify who has contracted Coronavirus, perhaps in an asymptomatic form and has produced antibodies, on April 20, 2020 in Milan, Italy.Commentary

    Sanofi CEO: How we can prevent being caught off guard by a pandemic like the coronavirus ever again

    By Paul Hudson
  • A heart graphic is seen displayed on an Apple Watch in this photo illustration in Warsaw, Poland on April 25, 2019.Commentary

    Pharma needs to stop chasing shiny objects and start embracing practical technology

    By Paul Hudson
    Rankings
    • 100 Best Companies
    • Fortune 500
    • Global 500
    • Fortune 500 Europe
    • Most Powerful Women
    • Future 50
    • World’s Most Admired Companies
    • See All Rankings
    Sections
    • Finance
    • Leadership
    • Success
    • Tech
    • Asia
    • Europe
    • Environment
    • Fortune Crypto
    • Health
    • Retail
    • Lifestyle
    • Politics
    • Newsletters
    • Magazine
    • Features
    • Commentary
    • MPW
    • CEO Initiative
    • Conferences
    • Personal Finance
    • Education
    Customer Support
    • Frequently Asked Questions
    • Customer Service Portal
    • Privacy Policy
    • Terms of Use
    • Single Issues for Purchase
    • International Print
    Commercial Services
    • Advertising
    • Fortune Brand Studio
    • Fortune Analytics
    • Fortune Conferences
    • Business Development
    About Us
    • About Us
    • Editorial Calendar
    • Press Center
    • Work at Fortune
    • Diversity and Inclusion
    • Terms and Conditions
    • Site Map

    © 2025 Fortune Media IP Limited. All Rights Reserved. Use of this site constitutes acceptance of our Terms of Use and Privacy Policy | CA Notice at Collection and Privacy Notice | Do Not Sell/Share My Personal Information
    FORTUNE is a trademark of Fortune Media IP Limited, registered in the U.S. and other countries. FORTUNE may receive compensation for some links to products and services on this website. Offers may be subject to change without notice.